A Lansing company has received government approval to test a new anthrax vaccine on humans.
BioPort, which is the nation's only anthrax vaccine supplier, has already conducted tests on humans.
But the Lansing-based company asked the US Food and Drug Administration if it could test the vaccine with an added immune-stimulating molecule.
The molecule could potentially reduce the number of doses necessary.
BioPort's research will be funded by the US Department of Defense.
WILX
500 American Road
Lansing, MI 48911
517-393-0110
- Copyright © 2002-2013 - Designed by Gray Digital Media - Powered by Limelight Networks
